Indeed, we have noticed that although chronic treatment with 20 mg/kg/day vildagliptin inhibits plasma DPPIV activity, it fails to inhibit the activity of the peptidase in the heart and in the kidneys of HF rats. This evidence concerns the gene DPP4 and hydrops fetalis.